Literature DB >> 24510992

Role of autophagy in apoptotic regulation by Akt in pancreatic cancer.

Diego Muilenburg1, Colin Parsons, Jodi Coates, Subbulakshmi Virudachalam, Richard J Bold.   

Abstract

BACKGROUND/AIM: The Akt signaling pathway mediates a potent anti-apoptotic signal in pancreatic cancer and inhibition of this pathway has become an attractive mechanism to increase the efficacy of traditional chemotherapies. Autophagy is a lysosomal catabolic pathway by which eukaryotic cells recycle macromolecules and organelles. Although autophagy may function as a survival mechanism under metabolic stress conditions, it also serves as an alternate route to programmed cell death distinct from apoptosis. In the present study, we examined the role of autophagy in Akt-mediated regulation of cell death in pancreatic cancer.
MATERIALS AND METHODS: Mia-PaCa-2 and PANC-1 human pancreatic cancer cell lines were used in our experiments. The small-molecule inhibitor A-443654 was used to inhibit Akt, and rapamycin was used to inhibit mTOR. Autophagy was inhibited with Chloroquine and 3-methyladenine. Autophagy was assessed by immunoblotting for light chain-3 (LC-3) processing as well as fluorescence microscopy for autophagosome formation following transfection with a LC-3/GFP construct. Cell death was determined by fluorescence-activated cell sorting (FACS) with quantitation of the sub-G0 content.
RESULTS: Inhibition of either Akt or mTOR induced autophagy; inhibition of Akt but not of mTOR led to traditional caspase-mediated apoptosis. When autophagy was inhibited, cell death was abrogated following Akt, but not mTOR, inhibition.
CONCLUSION: The Akt signaling pathway regulates both autophagy and apoptosis through divergent pathways; mTOR mediates autophagy signaling but appears to be un-involved in cell death. Autophagy appears to play a role in the regulation of cell survival by Akt, but only when proximal signaling pathways not involving mTOR are simultaneously activated.

Entities:  

Keywords:  AKT; Pancreatic cancer; autophagy; mTOR

Mesh:

Substances:

Year:  2014        PMID: 24510992      PMCID: PMC4565513     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  29 in total

1.  Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.

Authors:  Alexander Arlt; Andre Gehrz; Susanne Müerköster; Jens Vorndamm; Marie-Luise Kruse; Ulrich R Fölsch; Heiner Schäfer
Journal:  Oncogene       Date:  2003-05-22       Impact factor: 9.867

Review 2.  The role of autophagy in cancer: therapeutic implications.

Authors:  Zhineng J Yang; Cheng E Chee; Shengbing Huang; Frank A Sinicrope
Journal:  Mol Cancer Ther       Date:  2011-08-30       Impact factor: 6.261

3.  Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells.

Authors:  M S Tsao; S Chow; D W Hedley
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

4.  Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.

Authors:  Randie H Kim; Jodi M Coates; Tawnya L Bowles; Gregory P McNerney; Julie Sutcliffe; Jae U Jung; Regina Gandour-Edwards; Frank Y S Chuang; Richard J Bold; Hsing-Jien Kung
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

5.  Protein kinase B/Akt1 inhibits autophagy by down-regulating UVRAG expression.

Authors:  Wonseok Yang; Ji-hyun Ju; Kyung-min Lee; KeeSoo Nam; Sunhwa Oh; Incheol Shin
Journal:  Exp Cell Res       Date:  2012-11-30       Impact factor: 3.905

6.  Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.

Authors:  Hiroshi Aoki; Yasunari Takada; Seiji Kondo; Raymond Sawaya; Bharat B Aggarwal; Yasuko Kondo
Journal:  Mol Pharmacol       Date:  2007-03-29       Impact factor: 4.436

7.  The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.

Authors:  Takayuki Asano; Yixin Yao; Jijiang Zhu; Donghui Li; James L Abbruzzese; Shrikanth A G Reddy
Journal:  Oncogene       Date:  2004-11-11       Impact factor: 9.867

Review 8.  Metabolic stress in autophagy and cell death pathways.

Authors:  Brian J Altman; Jeffrey C Rathmell
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

9.  AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2.

Authors:  B N Fahy; M Schlieman; S Virudachalam; R J Bold
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

Review 10.  Emerging regulation and functions of autophagy.

Authors:  Patricia Boya; Fulvio Reggiori; Patrice Codogno
Journal:  Nat Cell Biol       Date:  2013-07       Impact factor: 28.824

View more
  9 in total

1.  Autophagy response in the liver of pigeon exposed to avermectin.

Authors:  Xian-Song Wang; Ci Liu; Pervez Ahmed Khoso; Weijia Zheng; Ming Li; Shu Li
Journal:  Environ Sci Pollut Res Int       Date:  2016-02-17       Impact factor: 4.223

Review 2.  Untangling knots between autophagic targets and candidate drugs, in cancer therapy.

Authors:  Tao Xie; Si-Jia Li; Ming-Rui Guo; Yue Wu; Hang-Yu Wang; Ke Zhang; Xue Zhang; Liang Ouyang; Jie Liu
Journal:  Cell Prolif       Date:  2015-02-04       Impact factor: 6.831

3.  Autophagy inhibition improves the chemotherapeutic efficacy of cruciferous vegetable-derived diindolymethane in a murine prostate cancer xenograft model.

Authors:  Hossam Draz; Alexander A Goldberg; Emma S Tomlinson Guns; Ladan Fazli; Stephen Safe; J Thomas Sanderson
Journal:  Invest New Drugs       Date:  2018-04-02       Impact factor: 3.850

4.  Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells.

Authors:  Feng Wang; Qi Wang; Zhi-Wei Zhou; Song-Ning Yu; Shu-Ting Pan; Zhi-Xu He; Xueji Zhang; Dong Wang; Yin-Xue Yang; Tianxing Yang; Tao Sun; Min Li; Jia-Xuan Qiu; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-01-17       Impact factor: 4.162

5.  Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.

Authors:  Feng Wang; Hai Li; Xiao-Gang Yan; Zhi-Wei Zhou; Zhi-Gang Yi; Zhi-Xu He; Shu-Ting Pan; Yin-Xue Yang; Zuo-Zheng Wang; Xueji Zhang; Tianxing Yang; Jia-Xuan Qiu; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-01-17       Impact factor: 4.162

6.  Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells.

Authors:  Jin-Long Hu; Xin-Long Hu; Ai-Ye Guo; Chao-Jie Wang; Yi-Yang Wen; Shun-Dong Cang
Journal:  Oncotarget       Date:  2017-07-25

7.  Glycolysis inhibition via mTOR suppression is a key step in cardamonin-induced autophagy in SKOV3 cells.

Authors:  Daohua Shi; Di Zhao; Peiguang Niu; Yanting Zhu; Jintuo Zhou; Huajiao Chen
Journal:  BMC Complement Altern Med       Date:  2018-12-04       Impact factor: 3.659

8.  Atractylenolide III Attenuates Muscle Wasting in Chronic Kidney Disease via the Oxidative Stress-Mediated PI3K/AKT/mTOR Pathway.

Authors:  Mingqing Wang; Rong Hu; Yanjing Wang; Lingyu Liu; Haiyan You; Jiaxing Zhang; Xiaohui Wu; Tingting Pei; Fujing Wang; Lu Lu; Wei Xiao; Lianbo Wei
Journal:  Oxid Med Cell Longev       Date:  2019-04-18       Impact factor: 6.543

9.  Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment.

Authors:  Adrian Zając; Joanna Sumorek-Wiadro; Ewa Langner; Iwona Wertel; Aleksandra Maciejczyk; Bożena Pawlikowska-Pawlęga; Jarosław Pawelec; Magdalena Wasiak; Monika Hułas-Stasiak; Dorota Bądziul; Wojciech Rzeski; Michał Reichert; Joanna Jakubowicz-Gil
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.